By Dr. Amy C. Moore, VP, Global Engagement and Patient Partnerships, October 27, 2021

Two couples at beach

This week, LUNGevity Foundation is launching a brand-new initiative called Lung Cancer Patient Gateways. The concept is to provide a “one-stop shop” of information and resources for patients and caregivers navigating a lung cancer diagnosis.


By Yovana Portillo, lung cancer survivor, October 25, 2021

Yovana Portillo

The first time I met with my representatives was in Washington, DC in 2018. It was part of a grassroots movement called Life & Breath Rally. We were each paired with another advocate and “cold called” our Congressional representatives, which basically meant we went to the Capitol and knocked on doors.


By LUNGevity Foundation, October 19, 2021

Dr. Fogelman

Some people with lung cancer have reduced lung function from their cancer or their treatments, like surgery, radiation, or chemotherapy. People with diminished lung functional capacity or shortness of breath may find pulmonary rehabilitation, a medical program that helps manage breathing, to be a helpful part of their palliative care.


By LUNGevity Foundation, October 18, 2021

Image of lungs made from lung cancer-related buzzwords

November is Lung Cancer Awareness Month, a time to educate the public about the disease, take action for and raise awareness of lung cancer, and share stories of the people living lung cancer  and their families.   

LUNGevity is spreading the word this Lung Cancer Awareness Month, and we hope you will join us to make a difference! There are plenty of ways to participate - check out five ideas to get you started below.


By Juhi Kunde, MA, LUNGevity Science Writer, October 15, 2021

Aaron Lisberg, MD

Checkpoint inhibitor immunotherapy has revolutionized lung cancer treatment and ushered in a new era of scientific discovery that is focused on empowering our natural immune system to target and eradicate lung cancer. While some patients see a strong long-lasting benefit from checkpoint inhibitor immunotherapy, there remains a significant proportion of patients with advanced non-small cell lung cancer (NSCLC) who do not show a lasting benefit.


By LUNGevity Foundation, October 14, 2021

Dr. Amy Moore

Editor's Note: Post was updated on 10/21 with new recommendations and authorizations. 

There has been a lot of information recently about COVID-19 boosters and who should get them and when. Here, LUNGevity’s Dr. Amy Moore, a PhD trained virologist and recognized expert on issues at the intersection of COVID-19 and lung cancer, answers some common questions about boosters and who should get them and when.


Share Your Story

Submit your story, blog idea, or lung cancer-specific article on the many issues people affected by lung cancer face

LUNGevity Spotlight

Nominate someone living with lung cancer or a caregiver, volunteer, or fundraiser who is making a positive impact in the LUNGevity community.

Ask Nutrition Questions

Your questions may be answered in an upcoming Savor Health blog post!